Literature DB >> 19018851

Clinicopathological features and prognosis of esophageal cancer in young patients. Is there a difference in outcome?

Atila Turkyilmaz1, Atilla Eroglu, Mahmut Subasi, Nurettin Karaoglanoglu.   

Abstract

The aim of this study was to define the clinicopathological features and prognosis of esophageal cancer in patients 40 years and younger. Between 1990 and 2007, 549 patients with esophageal cancer were enrolled in a retrospective database. Patients were divided into two age groups: Group A was under 40 years old, and group B over 40 years old. The findings for 50 patients (9.1%) aged 40 years or less were compared with those of 499 patients over 40 years old. In the younger group, there were significantly more women (35/15 vs. 231/268, P < 0.001). In the young and old groups, the most frequent histological morphology was squamous cell carcinoma (88% and 75%, respectively), although the percentages were significantly different (P < 0.005). In the younger group, lesions were more frequently located in the middle one-third of the esophagus than in the older group (64% vs. 28.3%, P < 0.001). Group A was more likely to have Stage IIa than older patients. In both groups, the surgical removal of the tumor was the most frequently used choice (70% vs. 56.5%). Survival rates in younger patients at 5 years after resection were 11.4%, similar to those in older patients (16.9%, difference not significant). In the group under age 40, women predominated. Squamous cell carcinoma was the most common histology, followed by adenocarcinoma. Younger patients did not have improved 5-year survival compared with their older counterparts.

Entities:  

Mesh:

Year:  2008        PMID: 19018851     DOI: 10.1111/j.1442-2050.2008.00890.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  6 in total

1.  Influence of young age on outcome after esophagectomy for cancer.

Authors:  Anna M J van Nistelrooij; Elrozy R Andrinopoulou; Jan J B van Lanschot; Hugo W Tilanus; Bas P L Wijnhoven
Journal:  World J Surg       Date:  2012-11       Impact factor: 3.352

2.  Esophageal squamous cell cancer in a highly endemic region.

Authors:  Akwi W Asombang; Violet Kayamba; Mpala M Lisulo; Kathryn Trinkaus; Victor Mudenda; Edford Sinkala; Stayner Mwanamakondo; Themba Banda; Rose Soko; Paul Kelly
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

3.  The characteristics of oesophageal squamous cell carcinoma: an analysis of 1317 cases in southeastern China.

Authors:  Yuan-Xi Jiang; Dong-Wei Zhang; Ying Chen; Hui-Hui Sun; Shu-Chang Xu; Heng-Jun Gao
Journal:  Contemp Oncol (Pozn)       Date:  2015-05-13

4.  Effect of Extending the Original CROSS Criteria on Tumor Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients: A National Multicenter Cohort Analysis.

Authors:  Helena Hong Wang; Ellen C de Heer; Jan Binne Hulshoff; Gursah Kats-Ugurlu; Johannes G M Burgerhof; Boudewijn van Etten; John Th M Plukker; Geke A P Hospers
Journal:  Ann Surg Oncol       Date:  2020-11-28       Impact factor: 5.344

5.  Telomere shortening in the esophagus of Japanese alcoholics: relationships with chromoendoscopic findings, ALDH2 and ADH1B genotypes and smoking history.

Authors:  Junko Aida; Akira Yokoyama; Naotaka Shimomura; Ken-ichi Nakamura; Naoshi Ishikawa; Masanori Terai; Steven Poon; Masaaki Matsuura; Mutsunori Fujiwara; Motoji Sawabe; Tomio Arai; Kaiyo Takubo
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

6.  Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma.

Authors:  Ren-Wen Huang; Yin-Kai Chao; Yu-Wen Wen; Hsien-Kun Chang; Chen-Kan Tseng; Sheng-Chieh Chan; Yun-Hen Liu
Journal:  World J Surg Oncol       Date:  2014-05-29       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.